As expected, BPTES significantly suppressed the growth of primary IDH1 mutant AML cells as well as BC-CML cells, suggesting a clear glutamine dependency in both cases (Fig 4H). Here, IDH1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.